Financhill
Sell
45

INLX Quote, Financials, Valuation and Earnings

Last price:
$14.76
Seasonality move :
20.37%
Day range:
$13.38 - $14.90
52-week range:
$4.81 - $16.50
Dividend yield:
0%
P/E ratio:
227.25x
P/S ratio:
3.74x
P/B ratio:
5.87x
Volume:
1.9K
Avg. volume:
5.4K
1-year change:
186%
Market cap:
$61.3M
Revenue:
$16.9M
EPS (TTM):
-$0.10
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $2.5M $8.3M $11.5M $14M $16.9M
Revenue Growth (YoY) 6.49% 225.46% 38.86% 22.31% 20.47%
 
Cost of Revenues $567.8K $3.3M $4.5M $5.1M $6.3M
Gross Profit $2M $5M $6.9M $8.9M $10.6M
Gross Profit Margin 77.61% 60.47% 60.58% 63.56% 62.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.1M $4.5M $5.4M $6.9M $8.5M
Other Inc / (Exp) -- -$1.9M $703.7K -$442.9K --
Operating Expenses $3.1M $4.8M $5.8M $7.6M $9.5M
Operating Income -$1.2M $153K $1.1M $1.3M $1.1M
 
Net Interest Expenses $980.7K $637.7K $452.1K $803.3K $588.2K
EBT. Incl. Unusual Items -$2.1M -$2.4M $1.4M $24K $519.3K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$188.3K -- -- --
Net Income to Company -$2.1M -$2.2M $1.4M $24K $519.3K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.1M -$2.2M $1.4M $24K $519.3K
 
Basic EPS (Cont. Ops) -$5.76 -$0.91 $0.48 $0.01 $0.13
Diluted EPS (Cont. Ops) -$5.76 -$0.91 $0.44 $0.01 $0.11
Weighted Average Basic Share $370.3K $2.4M $2.8M $3.8M $4.1M
Weighted Average Diluted Share $370.3K $2.4M $3.1M $4.3M $4.7M
 
EBITDA -$1.1M -$1M $2.9M $1.6M $2.1M
EBIT -$1.2M -$1.8M $1.8M $827.3K $1.1M
 
Revenue (Reported) $2.5M $8.3M $11.5M $14M $16.9M
Operating Income (Reported) -$1.2M $153K $1.1M $1.3M $1.1M
Operating Income (Adjusted) -$1.2M -$1.8M $1.8M $827.3K $1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.5M $3.2M $3.9M $4.2M $4.6M
Revenue Growth (YoY) 232.37% 26.29% 21.7% 10.07% 8.03%
 
Cost of Revenues $1M $1.3M $1.4M $1.6M $1.8M
Gross Profit $1.5M $1.9M $2.5M $2.6M $2.8M
Gross Profit Margin 59.34% 60.41% 64.93% 61.33% 61.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1M $1.4M $1.8M $2M $2.8M
Other Inc / (Exp) -- -- -$28.5K -- --
Operating Expenses $1.2M $1.5M $2M $2.3M $3.1M
Operating Income $271.2K $409.5K $486.5K $345.6K -$298.2K
 
Net Interest Expenses $115.5K $113K $240.5K $136.2K $94.6K
EBT. Incl. Unusual Items $155.7K $296.4K $217.5K $209.3K -$392.9K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $155.7K $296.4K $217.5K $209.3K -$392.9K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $155.7K $296.4K $217.5K $209.3K -$392.9K
 
Basic EPS (Cont. Ops) $0.06 $0.11 $0.05 $0.05 -$0.09
Diluted EPS (Cont. Ops) $0.06 $0.10 $0.05 $0.05 -$0.09
Weighted Average Basic Share $2.8M $2.8M $4.1M $4.1M $4.2M
Weighted Average Diluted Share $2.8M $3.1M $4.7M $4.4M $4.2M
 
EBITDA $479.2K $695.7K $663.9K $606.5K $7.7K
EBIT $271.2K $409.5K $458K $345.6K -$298.2K
 
Revenue (Reported) $2.5M $3.2M $3.9M $4.2M $4.6M
Operating Income (Reported) $271.2K $409.5K $486.5K $345.6K -$298.2K
Operating Income (Adjusted) $271.2K $409.5K $458K $345.6K -$298.2K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.2M $11.4M $12.7M $16.7M $17.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.3M $4.5M $4.8M $6.3M $6.5M
Gross Profit $3.9M $6.9M $7.9M $10.4M $11.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.1M $5.4M $6.2M $8.2M $10.3M
Other Inc / (Exp) -$349K -$786.9K -$564.5K $57.3K --
Operating Expenses $4.3M $5.8M $6.8M $9.1M $11.4M
Operating Income -$417.4K $1.1M $1.1M $1.3M $20.9K
 
Net Interest Expenses $785.8K $454.3K $706.3K $678.1K $451.8K
EBT. Incl. Unusual Items -$1.6M -$95.7K -$150.5K $658.4K -$430.9K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$188.3K -- -- -- --
Net Income to Company -$1.4M -$95.7K -$150.5K $658.4K -$430.9K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.4M -$95.7K -$150.5K $658.4K -$430.9K
 
Basic EPS (Cont. Ops) -$2.18 -$0.03 -$0.04 $0.17 -$0.09
Diluted EPS (Cont. Ops) -$2.18 -$0.08 -$0.04 $0.17 -$0.10
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$271.1K $1.4M $1.4M $2.3M $1.2M
EBIT -$766.4K $358.7K $555.8K $1.3M $20.9K
 
Revenue (Reported) $6.2M $11.4M $12.7M $16.7M $17.9M
Operating Income (Reported) -$417.4K $1.1M $1.1M $1.3M $20.9K
Operating Income (Adjusted) -$766.4K $358.7K $555.8K $1.3M $20.9K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.6M $8.7M $10M $12.7M $13.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1M $3.4M $3.7M $4.9M $5M
Gross Profit $3.4M $5.3M $6.3M $7.8M $8.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3M $4.1M $4.9M $6.2M $8M
Other Inc / (Exp) -$349K $767.9K -$500.3K -- --
Operating Expenses $3.5M $4.4M $5.4M $6.9M $8.9M
Operating Income -$89.5K $903.1K $917.1K $926K -$160.6K
 
Net Interest Expenses $522.7K $339.3K $593.6K $468.3K $331.9K
EBT. Incl. Unusual Items -$961.2K $1.3M -$176.8K $457.6K -$492.5K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$188.3K -- -- -- --
Net Income to Company -$772.9K $1.3M -$176.8K $457.6K -$492.5K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$772.9K $1.3M -$176.8K $457.6K -$492.5K
 
Basic EPS (Cont. Ops) -$0.58 $0.48 -$0.05 $0.11 -$0.11
Diluted EPS (Cont. Ops) -$0.58 $0.43 -$0.05 $0.11 -$0.11
Weighted Average Basic Share $6.8M $8.5M $11M $12.2M $12.6M
Weighted Average Diluted Share $6.8M $9.3M $11.6M $12.9M $13.1M
 
EBITDA $44.7K $2.4M $940.9K $1.7M $718.9K
EBIT -$438.5K $1.7M $416.8K $926K -$160.6K
 
Revenue (Reported) $5.6M $8.7M $10M $12.7M $13.7M
Operating Income (Reported) -$89.5K $903.1K $917.1K $926K -$160.6K
Operating Income (Adjusted) -$438.5K $1.7M $416.8K $926K -$160.6K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $404.2K $1.9M $1.8M $2.7M $1.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $329.6K $792.4K $1.2M $1.1M $1.9M
Inventory $4.2K $79.8K $76.7K $73.2K $110.3K
Prepaid Expenses -- -- -- -- --
Other Current Assets $110.8K $130.9K $155.6K $325.5K $367.5K
Total Current Assets $872.1K $3.5M $3.7M $4.9M $5M
 
Property Plant And Equipment $104.2K $3.3M $4.9M $4.4M $3.7M
Long-Term Investments -- -- -- -- --
Goodwill -- $2.3M $2.3M $5.8M $5.8M
Other Intangibles -- $1.2M $968.5K $4.4M $3.9M
Other Long-Term Assets $10.3K $31.3K $53.1K $417.5K $645.8K
Total Assets $986.6K $10.3M $12M $19.9M $19M
 
Accounts Payable $160.9K $141.8K $181.5K $370.3K $194.5K
Accrued Expenses $1.4M $137.6K $161.9K $114.9K $164.1K
Current Portion Of Long-Term Debt $4.8M $580.6K -- $937K --
Current Portion Of Capital Lease Obligations $47.4K $518.5K $616.1K $714.6K $762.5K
Other Current Liabilities -- $877.5K $958.8K $700K --
Total Current Liabilities $7.3M $3.6M $3.6M $6M $4.4M
 
Long-Term Debt -- $1.8M $1.8M $2.6M $2.8M
Capital Leases -- -- -- -- --
Total Liabilities $7.4M $9.2M $9.3M $11.4M $9.3M
 
Common Stock $370 $2.8K $2.8K $4.1K $4.1K
Other Common Equity Adj -- -- -- -- --
Common Equity -$6.4M $1.2M $2.7M $8.6M $9.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$6.4M $1.2M $2.7M $8.6M $9.8M
 
Total Liabilities and Equity $986.6K $10.3M $12M $19.9M $19M
Cash and Short Terms $404.2K $1.9M $1.8M $2.7M $1.2M
Total Debt $4.8M $2.4M $1.8M $3.6M $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.5M $1.8M $3.8M $1.7M $2.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1M $948.5K $853.9K $1.3M $1.3M
Inventory $80K $58.4K $74.5K $95.2K $89K
Prepaid Expenses -- -- -- -- --
Other Current Assets $207.2K $190.1K $324.6K $339.4K $380.1K
Total Current Assets $3.4M $3.7M $5.6M $4.9M $5.5M
 
Property Plant And Equipment $3.4M $5.1M $4.4M $3.9M $3.5M
Long-Term Investments -- -- -- -- --
Goodwill $2.3M $2.3M $5.8M $5.8M $5.8M
Other Intangibles $1.2M $1M $4.5M $4M $3.5M
Other Long-Term Assets $18.8K $14.8K $341.9K $624.2K $698.7K
Total Assets $10.4M $12.2M $20.8M $19.2M $19M
 
Accounts Payable $183.3K $121.5K $263.4K $249.4K $432.3K
Accrued Expenses $161.1K $153.6K $116.2K $223.3K $132.8K
Current Portion Of Long-Term Debt $612.5K -- $1.9M -- --
Current Portion Of Capital Lease Obligations $516.2K $596.3K $672.2K $762.4K $896.9K
Other Current Liabilities $287.4K $923.1K $757.4K -- --
Total Current Liabilities $3.1M $3.8M $7.1M $4.8M $5.7M
 
Long-Term Debt $1.8M $1.7M $2.6M $2.7M $1.3M
Capital Leases -- -- -- -- --
Total Liabilities $7.8M $9.6M $12.5M $9.9M $8.6M
 
Common Stock $2.8K $2.8K $4.1K $4.1K $4.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.6M $2.6M $8.2M $9.4M $10.4M
 
Total Liabilities and Equity $10.4M $12.2M $20.8M $19.2M $19M
Cash and Short Terms $1.5M $1.8M $3.8M $1.7M $2.5M
Total Debt $2.4M $1.7M $4.5M $2.7M $1.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$2.1M -$2.2M $1.4M $24K $519.3K
Depreciation & Amoritzation $49K $702.2K $1M $728.9K $1M
Stock-Based Compensation $200.1K $58.8K $92.3K $364K $464.5K
Change in Accounts Receivable -$180.4K $381K -$293.8K -$70.4K -$1.5M
Change in Inventories $1.5K $800 -$5.9K $3.5K -$37.1K
Cash From Operations -$982.2K $125K $1.4M $2M $784.7K
 
Capital Expenditures $5.5K $76.9K $590.5K $577.3K $548.1K
Cash Acquisitions -- -$4M -- -$6.4M --
Cash From Investing -$5.5K -$4.1M -$590.5K -$7M -$548.1K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $350K $3M -- $3M --
Long-Term Debt Repaid -$46.8K -$217.7K -- -$1M -$1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$483.8K -$954.7K -$1.8M -$702.4K
Cash From Financing $303.2K $5.5M -$954.7K $5.9M -$1.7M
 
Beginning Cash (CF) $1.1M $404.2K $1.9M $1.8M $2.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$684.5K $1.5M -$155.3K $943.9K -$1.5M
Ending Cash (CF) $404.2K $1.9M $1.8M $2.7M $1.2M
 
Levered Free Cash Flow -$987.7K $48.1K $799.5K $1.4M $236.6K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $155.7K $296.4K $217.5K $209.3K -$392.9K
Depreciation & Amoritzation $208.1K $286.3K $205.9K $261K $305.9K
Stock-Based Compensation $14K $23.1K $119K $115.5K $490K
Change in Accounts Receivable -$525.2K -$89K -$59.4K -$269K $527.4K
Change in Inventories $3.4K $2.5K $10.6K -$22.6K $4.9K
Cash From Operations -$259.9K $821.1K $1.9M $1.4M $1.9M
 
Capital Expenditures $33.7K $132.5K $188.6K $141K $296.6K
Cash Acquisitions -$1.3K -- -- -- --
Cash From Investing -$35K -$132.5K -$188.7K -$141K -$296.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$70K -- -- -$728.4K -$815.9K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$70K -- -- -$728.4K -$815.9K
 
Beginning Cash (CF) $1.9M $1.1M $2.1M $1.1M $1.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$364.8K $688.6K $1.7M $558.6K $821.1K
Ending Cash (CF) $1.5M $1.8M $3.8M $1.7M $2.5M
 
Levered Free Cash Flow -$293.5K $688.6K $1.7M $1.3M $1.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.4M -$95.7K -$150.5K $658.4K -$430.9K
Depreciation & Amoritzation $495.3K $993.6K $799K $948.3K $1.2M
Stock-Based Compensation $49.3K $95.4K $267.9K $468.1K $1.3M
Change in Accounts Receivable $146.3K -$23.3K $302.6K -$1.3M $179.4K
Change in Inventories $5.1K $8K -$16.1K -$20.6K $6.1K
Cash From Operations -$628.9K $1.9M $1.9M $1.2M $3.3M
 
Capital Expenditures $55.6K $553.4K $516.4K $551.3K $811.4K
Cash Acquisitions -$4M -- -$6.4M -- --
Cash From Investing -$4.1M -$553.4K -$6.9M -$551.3K -$811.4K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3.4M -- -- -- --
Long-Term Debt Repaid -- -- -- -$2M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$700K --
Cash From Financing $5.9M -- $6.9M -$2.7M -$1.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2M $317.3K $1.9M -$2.1M $812.6K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$684.5K $1.4M $1.4M $641K $2.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$772.9K $1.3M -$176.8K $457.6K -$492.5K
Depreciation & Amoritzation $483.2K $774.6K $524.1K $743.4K $879.5K
Stock-Based Compensation $32.7K $69.3K $245K $349.1K $1.2M
Change in Accounts Receivable $128.9K -$275.4K $321K -$944K $766.3K
Change in Inventories $5.1K $12.4K $2.2K -$21.9K $21.2K
Cash From Operations -$392.2K $1.4M $1.9M $1.1M $3.7M
 
Capital Expenditures $55.6K $532.1K $458K $432.1K $695.3K
Cash Acquisitions -$4M -- -$6.4M -- --
Cash From Investing -$4.1M -$532.2K -$6.8M -$432.1K -$695.4K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3M -- $3M -- --
Long-Term Debt Repaid -$117.7K -- -- -$1M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$483.8K -$954.7K -$1.8M -$700K --
Cash From Financing $5.6M -$954.7K $6.9M -$1.7M -$1.7M
 
Beginning Cash (CF) $3.3M $5.1M $6M $5.2M $4.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.1M -$78.6K $2M -$1M $1.3M
Ending Cash (CF) $4.4M $5M $8.1M $4.2M $5.4M
 
Levered Free Cash Flow -$447.7K $876.1K $1.5M $696.3K $3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock